Thursday, 9 May 2024
  
Login

Australia's most trusted
source of pharma news

Thursday, 09 May 2024
Listen to this story 
News

MA CEO hails vaccine report

Posted 26 April 2024 AM

Medicines Australia's CEO, Liz de Somer, has again called on the Federal Government to lower the discount rate for vaccines with a new report showing vaccination programs deliver 19 times return on investment.

The first-of-its-kind benefit-cost analysis of adult immunisation programs by the Office of Health Economics and commissioned by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), looked at programs against influenza, pneumococcal disease, herpes zoster, and respiratory syntical virus (RSV) across 10 countries, including Australia.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (5)

Sales & Customer Relations (23)

Clinical & Medical, R&D (11)

Regulatory, Pharmacovigilance & QA (10)

Other (30)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.